So far, only two retroviruses, human immunodeficiency virus (HIV)(type 1 and 2) and human
T-cell lymphotropic virus type 1 (HTLV-1), have been recognized as pathogenic for humans …

Neurologic disease is commonly encountered in the population infected with human
immunodeficiency virus type 1 (HIV-1). Although HIV-1 is responsible for many of these …

Background. Human T cell lymphotropic virus type 2 (HTLV-2) infection is not rare among
injection drug users with human immunodeficiency virus (HIV) infection and may exert a …

Infection of the central nervous system by the type 1 human immunodeficiency virus (HIV-1)
commonly results in a number of neurological impairments known, in their most severe form …

Objective: To determine whether subjects coinfected with HTLV-I and HIV have a higher
frequency of myelopathy than subjects singly infected with HIV. Design: A prospective …

Neurological manifestations are frequent in human immunodeficiency virus (HIV)-infected
patients and represent a great diagnostic and therapeutic challenge. They may be caused …

Abstract Purpose of Review The purpose of this review is to summarize the current
knowledge on the role of CD4+ T lymphocytes leading to HIV assault and persistence in the …

Almost 65 million people worldwide have been infected with HIV since it was first identified
in the early 1980s. Neurologic disorders associated with HIV type 1 affect between 40% and …

Despite the widespread success of combination antiretroviral therapy (cART) in reducing
morbidity and mortality in human immunodeficiency virus 1 (HIV-1) infection, HIV-associated …

Since the identification of human immunodeficiency virus type 1 (HIV‐1) in 1983, many
improvements have been made to control viral replication in the peripheral blood and to …